Vagus Nerve Stimulation For Heart Failure Fails To Impress, But BioControl Not Bothered
This article was originally published in The Pink Sheet Daily
Executive Summary
Data from two trials of vagus nerve stimulation to treat heart failure, sponsored by Boston Scientific and Cyberonics, respectively, were not particularly positive for the future of this therapy. But another developer of a VNS system for heart failure, BioControl, says the results won’t affect its chances for approval.